Ophthalmology-based diseases in India are increasing. Annually, close to 5 million cataract surgeries are performed in India. The majority of these procedures involve intraocular lens implantation. Furthermore, as per a study done by L V Prasad Eye Institute (LVPEI), Hyderabad, published in 2019, by the year 2030, a staggering 275 million people are expected to be affected by dry eye disease. The projection is based on the current incidence rates of 45% of the country’s urban population. There is a significant and growing burden of moderate visual impairment in India. Based upon increasing burden of eye diseases and moderate growth in technological advancements, the market is expected to register a CAGR of 7.3%.
- Ophthalmic services are available in India through eye hospitals that are run by the government, corporations, and non-profit organizations. The out-of-pocket expenditure in private settings is relatively higher than those in government hospitals, yet there is a growing popularity for private eye centers, primarily due to their higher degree of sophistication and international compliance of eye-care standards. As per the 2016 published statistics by the International Council of Ophthalmology, there were about 15,000 ophthalmologists in India, which highlights the shortage and high burden among the doctors to tackle the patient population in India, which is among the primary restraining factors for this market.
Key Market Trends
The Cataract Surgery Devices Segment is Expected to Hold the Largest Share in the Market
In India, ophthalmic surgeons performed approximately 7 million cataract procedures in 2019, making cataract devices the largest overall market segment in the Indian ophthalmic devices market. Revenues from cataract surgery in India are expected to generate close to 30% of the total ophthalmic devices market revenue in the country. Cataract surgery remains the most effective way to help restore vision for people suffering from cataracts. According to the Downtoearth.org report of 2019, cataract is the leading cause of blindness in people above 50 years. The increasing number of cataract cases in the country is boosting the segment’s growth in the country.
The Indian ophthalmic device market is highly competitive, and it consists of a number of major players. Companies, such as Alcon Inc., Bausch & Lomb Inc., Johnson & Johnson, and Carl Zeiss Meditec AG, among others, hold substantial market shares in the ophthalmic device market. Recently, various developments have been taking place in the market. Moreover, in November 2017, Zeiss introduced the cloud-based cataract surgery planning platform, Veracity Surgical, and announced the integration with leading EMRs.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support